Literature DB >> 24648320

Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic, Uganda.

A Nakiwogga-Muwanga1, J Musaazi2, E Katabira3, W Worodria3, S Alamo Talisuna4, R Colebunders5.   

Abstract

We determined the retention rate of patients infected with HIV who resumed care after being tracked at the Infectious Diseases Clinic (IDC) in Kampala, Uganda. Between April 2011 and September 2013, patients who missed their clinic appointment for 8-90 days were tracked, and those who returned to the clinic within 120 days were followed up. The proportion of patients retained among tracked patients, and those who resumed care before tracking started was compared. At 18 months of follow up, 33 (39%) of the tracked patients and 72 (61%) of those who had resumed care before tracking started were retained in care. The most important cause of attrition among the traceable was self-transfer to another clinic (38 [73%] patients), whereas among those who resumed care before tracking was loss to follow up (LTFU) (32 [71%] patients). Tracked patients who resume care following a missed appointment are at high risk of attrition. To increase retention, antiretroviral therapy clinics need to adopt a chronic care model which takes into consideration patients' changing needs and their preference for self-management.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  AIDS; HIV; Uganda; antiretroviral therapy; loss to follow up; missed appointment; patients’ retention; resource-limited setting; resuming care; risk of attrition; tracking; treatment

Mesh:

Substances:

Year:  2014        PMID: 24648320     DOI: 10.1177/0956462414529098

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  7 in total

Review 1.  How the Term 'Self-Management' is Used in HIV Research in Low- and Middle-Income Countries: A Scoping Review.

Authors:  Victoria H Davis; Stephanie A Nixon; Kathleen Murphy; Cathy Cameron; Virginia A Bond; Jill Hanass-Hancock; Lauren Kimura; Margaret C Maimbolwa; J Anitha Menon; Erica Nekolaichuk; Patricia Solomon
Journal:  AIDS Behav       Date:  2022-04-16

2.  Is more research always needed? Estimating optimal sample sizes for trials of retention in care interventions for HIV-positive East Africans.

Authors:  Jennifer Uyei; Lingfeng Li; R Scott Braithwaite
Journal:  BMJ Glob Health       Date:  2017-07-20

3.  Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia.

Authors:  Alula M Teklu; Kesetebirhan D Yirdaw
Journal:  BMC Health Serv Res       Date:  2017-04-04       Impact factor: 2.655

4.  Interventions to reengage people living with HIV who are lost to follow-up from HIV treatment programs: A systematic review and meta-analysis.

Authors:  Ali Mirzazadeh; Ingrid Eshun-Wilson; Ryan R Thompson; Atousa Bonyani; James G Kahn; Stefan D Baral; Sheree Schwartz; George Rutherford; Elvin H Geng
Journal:  PLoS Med       Date:  2022-03-15       Impact factor: 11.613

5.  Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.

Authors:  Cristina Ardura-Garcia; Caryl Feldacker; Hannock Tweya; Thom Chaweza; Mike Kalulu; Sam Phiri; Duolao Wang; Ralf Weigel
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-15       Impact factor: 3.731

Review 6.  Improving retention in HIV care among adolescents and adults in low- and middle-income countries: A systematic review of the literature.

Authors:  Kate R Murray; Lisa S Dulli; Kathleen Ridgeway; Leila Dal Santo; Danielle Darrow de Mora; Patrick Olsen; Hannah Silverstein; Donna R McCarraher
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240

7.  Patterns and Predictors of Incident Return to HIV Care Among Traced, Disengaged Patients in Zambia: Analysis of a Prospective Cohort.

Authors:  Laura K Beres; Sheree Schwartz; Sandra Simbeza; John McGready; Ingrid Eshun-Wilson; Chanda Mwamba; Kombatende Sikombe; Stephanie M Topp; Paul Somwe; Aaloke Mody; Njekwa Mukamba; Peter D Ehrenkranz; Nancy Padian; Jake Pry; Carolyn Bolton Moore; Charles B Holmes; Izukanji Sikazwe; Julie A Denison; Elvin Geng
Journal:  J Acquir Immune Defic Syndr       Date:  2021-03-01       Impact factor: 3.771

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.